Table 4. Risk Factors for Major Complications with 2-Stage Hepatectomy.
Risk factor | Univariate p value | Multivariate* | |||
---|---|---|---|---|---|
Odds ratio | 95% Confidence interval | p Value | |||
Lower | Upper | ||||
Rectal primary tumor | 0.052 | 3.904 | 1.248 | 12.211 | 0.019 |
Primary tumor nodal status positive | 0.347 | ||||
Synchronous presentation of CLM | 0.081 | 0.295 | 0.091 | 0.953 | 0.041 |
> 5 CLM† | 0.295 | ||||
Diameter of largest metastasis > 5 cm† | 0.701 | ||||
> 6 cycles of chemotherapy before first-stage resection | 0.9 | ||||
Bevacizumab before first-stage resection | 0.468 | ||||
Interval chemotherapy after first-stage resection | 0.875 | ||||
Combined primary surgery at first-stage resection | 0.763 | ||||
Portal vein embolization | 0.474 | ||||
> 1 lesion resected during first-stage resection | 0.028 | 3.594 | 1.313 | 9.842 | 0.013 |
> 1 lesion resected during second-stage resection | 0.225 | ||||
RAS mutation | 0.308 |
Binary logistic regression, using enter method with 0.1 selection.
Based on computed tomography before chemotherapy.
CLM, colorectal liver metastases.